The CMTA-STAR Drug Development Pipeline offers a visual snapshot of active and emerging therapies being developed through CMTA’s Strategy To Accelerate Research (CMTA-STAR). Each bar on the pipeline represents a research program supported by CMTA, industry collaborators, or both.
The CMTA-STAR drug development pipeline reflects our commitment to moving treatments forward, from discovery through preclinical validation and into clinical trials. With more than 50 active programs and growing, the pipeline demonstrates the scale of momentum and collaboration powering progress in CMT research.
The CMTA-STAR Drug Development Pipeline
